Positive impactCorporate Action
Bonus issue alert! Last day to buy this microcap pharma stock that rallied 200% in one year
Economic Times 15 Jul·15 Jul 2026, 4:30 am
Fredun Pharmaceuticals has fixed July 16 as the record date for its 2:1 bonus issue, making today the last day to buy the stock to qualify. The microcap pharma stock has surged nearly 200% over the past year and 84% in 2026, reflecting strong investor interest and robust business momentum.
Affected stocks
Bullish1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Fredun Pharmaceuticals (FREDUN).
- Category: Corporate Action.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update for Fredun Pharmaceuticals. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
